Associated Papers
C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report.
Yanagidani H et al.
Bmc Nephrology, 2026
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.
Brocklebank V et al.
Blood, 2023
37369098 (PubMed )
Supplement: BLOOD_BLD-2022-018833R2-mmc1.pdf
Lipid-Related Genetic Variants for Personalized Dietary Interventions: A Systematic Review.
Rivera-Íñiguez I et al.
Molecular Nutrition & Food Research, 2023
Select a paper to view details